Skip to Main Content
 

Global Search Box

 
 
 
 

ETD Abstract Container

Abstract Header

Engineering Poly(Ethylene Glycol) Hydrogel Scaffolds to Modulate Smooth Muscle Cell Phenotype

Beamish, Jeffrey Alan

Abstract Details

2009, Doctor of Philosophy, Case Western Reserve University, Biomedical Engineering.
This work investigated the hypothesis that smooth muscle cell (SMC) phenotype can be modulated by a cell-instructive hydrogel scaffold. By modulating SMCs toward a quiescent contractile phenotype, such a scaffold may facilitate the regeneration of functional vascular tissue as part of a tissue engineered blood vessel (TEBV) and may mitigate SMC intimal hyperplasia, which is one of the common modes of vascular prosthesis failure. A photopolymerizable poly(ethylene glycol) diacrylate (PEGDA) hydrogel system was employed because this scaffold material can be engineered quantitatively to meet a broad range of physical and biological design specifications. PEGDA hydrogel networks were copolymerized with poly(ethylene glycol) monoacrylate (PEGMA), which could tether pendent cell-adhesive peptides to the network. The physical characteristics of a range of copolymer network compositions (5-20% w/w PEGDA, 0-20% PEGMA) were determined and analyzed for the scaffold design. Mass swelling ratio (7.5±0.1 to 27.1±0.7) and shear modulus (4.0±0.6 to 104±4 kPa) data indicated that hydrogel properties were controlled quantitatively and independently of PEGMA concentration. SMCs attached to PEGDA-co-GRGDSP-PEGMA (RGD-gels) in a ligand specific manner. RGD-gels also supported modulation toward a contractile SMC phenotype that was indistinguishable from fibronectin control substrates. In these experiments, low serum medium with heparin induced rapid up-regulation of contractile phenotype marker mRNA (2.7- to 25-fold) and proteins, as well as intracellular organization of these markers. Based on these results, RGD-bearing PEGDA hydrogel scaffolds were engineered to modulate SMC phenotype by providing controlled release of heparin. Using PEGDA molecular weight (1-6 kD) and concentration (10-30% w/w), a broad range of release profiles was achieved with durations from hours to weeks. These cell-instructive scaffolds stimulated up-regulation of contractile phenotype markers (~1.5-fold) that was driven by released heparin. These results suggest that the delivery of soluble signaling factors, such as heparin, from an RGD-gel scaffold is an effective approach to induce rapid changes in SMC phenotype. A cell-instructive scaffold system, such as described here, will facilitate the engineering of functional smooth muscle tissue for a variety of applications and may improve the long-term patency of TEBVs.
Roger E. Marchant, PhD (Committee Chair)
Kandice Kottke-Marchant, MD, PhD (Advisor)
Eben Alsberg, PhD (Committee Member)
George R. Dubyak, PhD (Committee Member)
286 p.

Recommended Citations

Citations

  • Beamish, J. A. (2009). Engineering Poly(Ethylene Glycol) Hydrogel Scaffolds to Modulate Smooth Muscle Cell Phenotype [Doctoral dissertation, Case Western Reserve University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=case1246649015

    APA Style (7th edition)

  • Beamish, Jeffrey. Engineering Poly(Ethylene Glycol) Hydrogel Scaffolds to Modulate Smooth Muscle Cell Phenotype. 2009. Case Western Reserve University, Doctoral dissertation. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=case1246649015.

    MLA Style (8th edition)

  • Beamish, Jeffrey. "Engineering Poly(Ethylene Glycol) Hydrogel Scaffolds to Modulate Smooth Muscle Cell Phenotype." Doctoral dissertation, Case Western Reserve University, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=case1246649015

    Chicago Manual of Style (17th edition)